RLMD Q3'26 Earnings: EPS estimate is (0.14) USD

RLMD (Relmada Therapeutics, Inc.) is set to announce its Q3'26 results on November 12, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (9:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.14) USD. Learn more details at R…